Quantitative analysis in molecular diagnostics

Human Pathology

Volumn 25, Issue 6, 1994, Pages 572-579

  Crotty, Paul L ^a   Staggs, Rodney A ^a   Porter, Priscilla T ^a   Killeen, Anthony A ^a   McGlennen, Ronald C ^a  

^a University of Minnesota   (United States)

Author keywords

electrochemiluminescence; exponential phase; ligase chain reaction; plateau effect; polymerase chain reaction

Indexed keywords

CHEMOLUMINESCENCE; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA DETERMINATION; FLUORESCENCE; GENE AMPLIFICATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; POLYMERASE CHAIN REACTION; QUALITATIVE DIAGNOSIS;

BONE MARROW TRANSPLANTATION; CHEMISTRY, ANALYTICAL; GENOTYPE; HUMAN; NUCLEIC ACIDS; POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 0028308674     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/0046-8177(94)90221-6     Document Type: Article

References (61)

1. Chronic myelogenous leukemia: Molecular diagnostic considerations
2. Specific enzymatic amplification of DNA in vitro: The polymerase chain reaction
3. Quantitation of mRNA by the polymerase chain reaction
4. Quantitative or semi-quantitative PCR: Reality versus myth
5. Quantitative PCR and RT-PCR in virology
6. General aspects of PCR quantitation
7. Quantitative evaluation of gene expression in freshly isolated human respiratory epithelial cells
8. Detection of rare mRNAs via quantitative RT-PCR
9. Plateau effect: Understanding PCR limitations
10. Rapid synthesis of DNA deletion constructs for mRNA quantitation: Analysis of astrocyte mRNA
11. Comparative method for detection of RNA-PCR-amplified signals
12. Automated DNA profiling by fluorescent labeling of PCR products
13. Genetic typing using automated electrophoresis and fluorescence detection
14. Fluorescent multiplex linkage analysis and carrier detection for Duchenne/Becker muscular dystrophy
15. Quantitation of polymerase chain reaction products by hybridization-based assays with fluorescent, colorimetric, or chemiluminescent detection
16. Detection of polymerase chain reaction-amplified human immunodeficiency virus type 1 proviral DNA with a digoxigenin-labeled RNA probe and an enzymelinked immunoassay
17. Measurement of mRNA by quantitative PCR with a nonradioactive label
18. A high sensitivity electrochemiluminescence-based detection system for automated PCR product quantitation
19. Rapid non-separation electrochemiluminescent DNA hybridization assays for PCR products using 3′-labelled oligonucleotide probes
20. Electrochemiluminescent detection and quantitation of PCR-amplified DNA
21. Rapid separation, quantitation and purification of products of polymerase chain reaction by liquid chromatography
22. A new quantitative polymerase chain reaction-high performance ion exchange liquid chromatographic method for the detection of fibroblast growth factor-beta (FGF-beta) gene amplification
23. A ligase-mediated gene detection technique
24. Genetic disease detection and DNA amplification using cloned thermostable ligase
25. Restriction fragment length polymorphisms as markers of engraftment in allogeneic marrow transplantation
26. Analysis of late graft failure after allogeneic bone marrow transplantation: Detection of residual host cells using amplification of variable number of variable number of tandem repeats loci
27. Analysis of the VNTR locus D1S80 by the PCR followed by high resolution PAGE
28. Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction: Application to the apolipoprotein B 3′ hypervariable region
29. Monitoring of residual disease in chronic myelogenous leukemia by quantitative polymerase chain reaction
30. Molecular quantification of residual disease in chronic myelogenous leukemia after bone marrow transplantation
31. Early detection of relapse after bone marrow transplantation in patients with chronic myelogenous leukaemia
32. Use of the polymerase chain reaction in the quantitation of mdr-1 gene expression
33. Quantitative analysis of MDR1 gene expression in human tumors by polymerase chain reaction
34. Function and regulation of the human multidrug resistance gene
35. Detection and temporal appearance of multiple copies of c-erb-B2 genes in advanced mammary carcinoma using fine needle biopsies and the polymerase chain reaction
36. Nonisotopic SSCP and competitive PCR for DNA quantification: p53 In breast cancer cells
37. Concurrent mutations of coding and regulatory sequences of the Ha-ras gene in urinary bladder carcinomas
38. Analysis of quantitative PCR for the diagnosis of deletion and duplication carriers in the dystrophin gene
39. Sequencing and quantitative assessment of mutant and wild-type mitochondrial DNA in paraffin sections from cases of MELAS
40. Accumulation of deletions in human mitochondrial DNA during normal aging: Analysis by quantitative PCR
41. Diagnosis of Down syndrome and other aneuploidies using quantitative polymerase chain reaction and small tandem repeat polymorphisms
42. Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals
43. Relevance of the quantitative detection of HIV proviral sequences in PBMC of infected individuals
44. Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction
45. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR
46. HIV-1 plasma viraemia quantification: A non-culture measurement needed for therapeutic trials
47. Correlation between the serum level of hepatitis C virus RNA and disease activities in acute and chronic hepatitis C
48. Quantitative analysis of hepatitis C virus RNA in serum during interferon alpha therapy
49. Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: Increase of the virus in advanced liver disease
50. Increased human T lymphotropic virus type-1 (HTLV-1) proviral DNA in peripheral blood mononuclear cells and bronchoalveolar lavage cells from Japanese patients with HTLV-1-associated myelopathy
51. Quantitation of cytomegalovirus DNA in lung tissue of bone marrow transplant recipients
52. Quantitative and qualitative comparison of DNA amplification by PCR with immunofluorescence staining for diagnosis of Pneumocystis carinii pneumonia
53. Long persistent bcr-abl positive transcript detected by polymerase chain reaction after marrow transplant for chronic myelogenous leukemia without clinical relapse: A study of 64 patients
54. Regulation of human renin secretion and renin transcription by quantitative PCR in cultured chorionic cells: Synergistic effect of cyclic AMP and protein kinase C
55. Gene expression of the reninangiotensin system in human tissues. Quantitative analysis by the polymerase chain reaction
56. Thyroxine increases the levels of epidermal growth factor messenger ribonucleic acid (EGF mRNA) in the thyroid in vivo, as revealed by quantitative reverse transcription polymerase chain reaction with an internal control EGF mRNA
57. The relative expression of mutant and normal thyroid hormone receptor genes in patients with generalized resistance to thyroid hormone determined by estimation of their specific messenger ribonucleic acid products
58. Electroconvulsive shock alters GABAA receptor subunit mRNAs: Use of quantitative PCR methodology
59. A PCR method for the quantitative assessment of mRNA for laminin A, B1, and B2 chains
60. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle